Ignite Creation Date:
2024-05-06 @ 12:17 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01530334
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2012-01-31
Brief Title:
Iressa Re-Challenge in Advanced NSCLC EGFR M Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment
Sponsor:
Organization:
AstraZeneca